In vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim..
Gold nanoparticles (AuNP) have been widely used for drug delivery and have recently been explored for applications in cancer immunotherapy. Although AuNPs are known to accumulate heavily in the spleen, the particle distribution within immune cells has not been thoroughly studied. Here, cellular distribution of Cy5 labeled 50 nm AuNPs is characterized within the immune populations of the spleen from naïve and tumor bearing mice using flow cytometry. Surprisingly, approximately 30% of the detected AuNPs are taken up by B cells at 24 h, with about 10% in granulocytes, 18% in dendritic cells, and 8% in T cells. In addition, 3% of the particles are detected within myeloid derived suppressor cells, an immune suppressive population that could be targeted for cancer immunotherapy. Furthermore, it is observed that, over time, the particles traveled from the red pulp and marginal zone to the follicles of the spleen. Taking into consideration that the particle cellular distribution does not change at 1, 6 and 24 h, it is highly suggestive that the immune populations carry the particles and migrate through the spleen instead of the particles migrating through the tissue by cell-cell transfer. Finally, no difference is observed in particle distribution between naïve and tumor bearing mice in the spleen, and nanoparticles are detected within 0.7% of dendritic cells of the tumor microenvironment. Overall, these results can help inform and influence future AuNP delivery design criteria including future applications for nanoparticle-mediated immunotherapy.
| Media Type: |
Electronic Article |
|---|
| Year of Publication: |
2014 |
|---|---|
| Publication: |
2014 |
| Contained In: |
To Main Record - volume:10 |
|---|---|
| Contained In: |
Small (Weinheim an der Bergstrasse, Germany) - 10(2014), 4 vom: 26. Feb., Seite 812-9 |
| Language: |
English |
|---|
| Contributors: |
Almeida, Joao Paulo Mattos [Author] |
|---|
| Links: |
|---|
| Notes: |
Date Completed 19.10.2015 Date Revised 21.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/smll.201301998 |
|---|
| funding: |
|
|---|---|
| Supporting institution / Project title: |
|
| PPN (Catalogue-ID): |
NLM231603495 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM231603495 | ||
| 003 | DE-627 | ||
| 005 | 20240321233107.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/smll.201301998 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1338.xml |
| 035 | |a (DE-627)NLM231603495 | ||
| 035 | |a (NLM)24115675 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Almeida, Joao Paulo Mattos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.10.2015 | ||
| 500 | |a Date Revised 21.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. | ||
| 520 | |a Gold nanoparticles (AuNP) have been widely used for drug delivery and have recently been explored for applications in cancer immunotherapy. Although AuNPs are known to accumulate heavily in the spleen, the particle distribution within immune cells has not been thoroughly studied. Here, cellular distribution of Cy5 labeled 50 nm AuNPs is characterized within the immune populations of the spleen from naïve and tumor bearing mice using flow cytometry. Surprisingly, approximately 30% of the detected AuNPs are taken up by B cells at 24 h, with about 10% in granulocytes, 18% in dendritic cells, and 8% in T cells. In addition, 3% of the particles are detected within myeloid derived suppressor cells, an immune suppressive population that could be targeted for cancer immunotherapy. Furthermore, it is observed that, over time, the particles traveled from the red pulp and marginal zone to the follicles of the spleen. Taking into consideration that the particle cellular distribution does not change at 1, 6 and 24 h, it is highly suggestive that the immune populations carry the particles and migrate through the spleen instead of the particles migrating through the tissue by cell-cell transfer. Finally, no difference is observed in particle distribution between naïve and tumor bearing mice in the spleen, and nanoparticles are detected within 0.7% of dendritic cells of the tumor microenvironment. Overall, these results can help inform and influence future AuNP delivery design criteria including future applications for nanoparticle-mediated immunotherapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a biodistribution | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a gold nanoparticles | |
| 650 | 4 | |a immune system | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a spleen | |
| 650 | 7 | |a CD11c Antigen |2 NLM | |
| 650 | 7 | |a Gold |2 NLM | |
| 650 | 7 | |a 7440-57-5 |2 NLM | |
| 700 | 1 | |a Lin, Adam Yuh |e verfasserin |4 aut | |
| 700 | 1 | |a Langsner, Robert James |e verfasserin |4 aut | |
| 700 | 1 | |a Eckels, Phillip |e verfasserin |4 aut | |
| 700 | 1 | |a Foster, Aaron Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Drezek, Rebekah Anna |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Small (Weinheim an der Bergstrasse, Germany) |d 2005 |g 10(2014), 4 vom: 26. Feb., Seite 812-9 |w (DE-627)NLM167400452 |x 1613-6829 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2014 |g number:4 |g day:26 |g month:02 |g pages:812-9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/smll.201301998 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2014 |e 4 |b 26 |c 02 |h 812-9 | ||